ArticlePDF Available

Mitochondrial DNA alterations of peripheral lymphocytes in acute lymphoblastic leukemia patients undergoing total body irradiation therapy

Authors:

Abstract and Figures

Mitochondrial DNA (mtDNA) alterations, including mtDNA copy number and mtDNA 4977 bp common deletion (CD), are key indicators of irradiation-induced damage. The relationship between total body irradiation (TBI) treatment and mtDNA alterations in vivo, however, has not been postulated yet. The aim of this study is to analyze mtDNA alterations in irradiated human peripheral lymphocytes from acute lymphoblastic leukemia (ALL) patients as well as to take them as predictors for radiation toxicity. Peripheral blood lymphocytes were isolated from 26 ALL patients 24 hours after TBI preconditioning (4.5 and 9 Gy, respectively). Extracted DNA was analyzed by real-time PCR method. Average 2.31 times mtDNA and 0.53 fold CD levels were observed after 4.5 Gy exposure compared to their basal levels. 9 Gy TBI produced a greater response of both mtDNA and CD levels than 4.5 Gy. Significant inverse correlation was found between mtDNA content and CD level at 4.5 and 9 Gy (P = 0.037 and 0.048). Moreover, mtDNA content of lymphocytes without irradiation was found to be correlated to age. mtDNA and CD content may be considered as predictive factors to radiation toxicity.
Content may be subject to copyright.
RESEARCH Open Access
Mitochondrial DNA alterations of peripheral
lymphocytes in acute lymphoblastic leukemia
patients undergoing total body irradiation therapy
Quan Wen
1
, Yide Hu
1*
, Fuyun Ji
2
and Guisheng Qian
2
Abstract
Background: Mitochondrial DNA (mtDNA) alterations, including mtDNA copy nu mber and mtDNA 4977 bp
common deletion (CD), are key indicators of irradiation-induced damage. The relationship between total body
irradiation (TBI) treatment and mtDNA alterations in vivo, however, has not been postulated yet. The aim of this
study is to analyze mtDNA alterations in irradiated human peripheral lymphocytes from acute lymphoblastic
leukemia (ALL) patients as well as to take them as predictors for radiation toxicity.
Methods: Peripheral blood lymphocytes were isolated from 26 ALL patients 24 hours after TBI preconditioning (4.5
and 9 Gy, respectively). Extracted DNA was analyzed by real-time PCR method.
Results: Average 2.31 times mtDNA and 0.53 fold CD levels were observed after 4.5 Gy exposure compared to
their basal levels. 9 Gy TBI produced a greater response of both mtDNA and CD levels than 4.5 Gy. Significant
inverse correlation was found between mtDNA content and CD level at 4.5 and 9 Gy (P = 0.037 and 0.048).
Moreover, mtDNA content of lymphocytes without irradiation was found to be correlated to age.
Conclusions: mtDNA and CD content may be considered as predictive factors to radiation toxicity.
Keywords: mtDNA, 4977-bp Common deletion, Total body irradiation, Real-time-PCR, Acute lymphoblastic leukemia
Background
Breakage of cellular DNA following radiation is a dose
dependent phenomenon a nd occurs in both the nuclear
and extra-nuclear DNA. Thus, besides nuclear nDNA,
mitochondrial DNA (mtDNA) is equally affected as an
only extra-nuclear genome [1,2]. Numerous investigations
showed that mtDNA can be an easily av ailable target for
endogenous reactive oxygen species (ROS) and free radi-
cals ca used by ion izing radiation ( IR), which resulted in
mtDNA copy number alteration and mtDNA damage
(such as mutation and depletion) [3,4].
The mechanisms of cellular response to radiation with
regard to mtDNA alterations were mainly involved in the
following two ways. On one hand, mtDNA has few repair
mechanisms and continued mitochondrial function is pre-
served primarily due to its high copy number. One of
possible radio-protective m echanism is that enha nced
replication of mtDNA reduces the mutation frequency of
total mtDNA and delays the onset of lethal radiation
damage to the mitochondria [5,6]. This hypothesis has
been recently supported by Zhang et al with exhibiting
increased mtDNA copy number in gut and bone marrow
of total body irradiated rats [7]. On the other hand, IR
usually prompts cell apoptosis by displaying an accumula-
tion of large scale mtDNA deletions, especially the specific
4977 bp deletion, referred to as the common deletion
(CD)" [8]. The site of CD is flanked by two13 bp direct
repeats (ACCTCCCTCACCA) at mtDNA nucleotide site
8470 and 13447 respectively, and easy to make deletion
for its unique formation mechanism [9]. Studies have
shown that CD can be as a sensitive marker of oxidativ e
damage to mtDNA [10-12]. Unfortunately, only few
experiments have evaluated the association between
CD and I R till now. For example, accumulation of CD
has been identifie d by qualitative PCR method on several
irradiated cell lines (such as human skin fibroblasts,
* Correspondence: huyide_mit@yahoo.com.cn
1
Third Department of Oncology, The second affiliated hospital, Third Military
Medical University, Chongqing 400037, China
Full list of author information is available at the end of the article
Wen et al. Radiation Oncology 2011, 6:133
http://www.ro-journal.com/content/6/1/133
© 2011 Wen et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creative commons.org/licenses/by/2.0), whi ch permits unrestricted use, di stri bution, and reproduct ion in
any medium , provided the original work is properly cited.
glioblastoma and colon carcinoma lines) and primary lym-
phocytes [13-15]. Furthermore, CD was induced by IR in
human hepatoblastoma cell line performing on real-time
PCR with nonspecific dsDNA-binding dye SYBR Green.
However, their conclusions were largely controversial. The
inconsistency may be due, in part, to the use of non-quan-
titative PCR strategies. Additionally, none of these studies
have assayed mtDNA or CD level in peripheral blood lym-
phocytes (PBLs) after in vivo irradiation exposure for lack
of appropriate human beings radiation model.
In this study, we performed real-time PCR t echnique
with a specific fluorogenic TaqMan probe conjugated with
minor groove binder (MGB) groups, which is more sensi-
tive and appropriate than nonspecific dsDNA-binding dye
PCR methods previously used [16 ]. Besides, we ta ken the
acute lymphoblastic leukemia (ALL) patients undergoging
total body irradiation (TBI) precondionting as human
beings in vivo irradiation model. The advantage of using
this model lies in full view of in vivo microenvironment,
and without need for irradiating hea lthy i ndividuals. We
attempted to address t he mtDNA status in irradiated
human peripheral blood lymphocytes in vivo to elucidate
whether alterations in mtDNA can be li nked to exposure
to total body irradiation.
Materials and methods
Study participants
This study comprised peripheral blood (PB) samples from
26 high risked ALL patients undergoing TBI as pre-trans-
plantation treatment in their first complete remission
(CR1) at hematology department of our institution. The
diagnoses were. according to world healthy organization
(WHO) classification and high risk factors were measured
on Ribeca s report [17]. The patients age from 19 to 56
years with a mean of 39.4 ± 10.5. Of these, 10 are females
and 16 males. Besides, a total of 39 healthy volunteer indi-
viduals without IR were included in this study for compar-
ing the difference of basal mtDNA and CD levels between
ALL patients and normal donors before IR. The donors
age from 18 to 55 years with a mean of 37. 2 ± 9.4. 19 are
females and 20 males. All tested subjects signed an
informed consent to the use of blood samples in accor-
dance with the Declaration of Helsinki and with the
approval from our Institutional Review Board. The
amount of CD in skeletal muscle under physiological con-
ditions is relatively high (up to 1-2% from total mtDNA
content) [18]. Therefore, DNA isolated from skeletal mus-
cle of a 75-year-old male at autopsy was used as positive
control in the present study.
In vivo irradiation and peripheral blood lymphocyte
isolation
All patients were treated with two 4.5 Gy TBI sessions
daily using an Elekta SLi 8 MV linear accelerator (Elekta
Co., Stockholm, Sweden) set to deliver a dose rate of
4.5-4.9 cGy/min over two successive days. None of t he
patients had p rior exposure to any cytotoxic treatment
for at least 2 weeks before the start of radiotherapy. All
patients had 7 ml of PB collected prior to and 24 h fol-
lowing exposure for each radiation treatment. Besides,
39 healthy do nors had the sam e volume of PB collected
without ionizing radiation. Preparation of PBLs followed
standard methods, using human lymphocyte isolation
reagent (TBD Biological Technology Co., Tianjin,
China) for separation of mononuclear cells.
DNA extraction
DNA from lymphocytes in vivo and the skeletal muscle
was obtained with the TIANamp Genomic DNA Kit
(Tiangen Ltd, Beijing, China), and stored at -70°C until
further study.
Analysis of amount of mtDNA and CD by real-time PCR
TaqMan probes with conjugated MGB groups were per-
formed to ensure maximal specificity in real-time PCR
reaction. Nuclear DNA content was estimated by mea-
suring the human ß-actin gene. The hypervariable region
2 (HVR2) in the mitochondrial D-Loop was used to
represent the total amount of mtDNA since this region is
relatively conserved in Han Chinese [19]. The forward
primer (ß-actin: 5-AGGACCCTGGATGTGACAGC-3;
HVR2: 5 -GCTTTCCACACAGACATCATAACAA- 3;
CD: 5 -CTTACACTATTCC TCATCACCCAACTAA
AAA-3), reverse primer (ß-actin: 5-TGGCATTGCCGA-
CAGGAT-3;HVR2:5-GTTTAAGTGCTGTGG CCA-
GAAG-3 ;CD:5 -GGAGTAGAAACCTGTGAGGAA
AGG-3 ) and Taq Man MGB hybridization probes
(ß-actin: 5 -AAAGACACCCACCTTGAT-3 ;HVR2:5-
AATTTCCACCAAACCCC-3; CD: 5-CATTGGCAGCC
TAGC ATT-3 ) were synthesized by GeneCore Bio Tech-
nologies Co. Ltd., Shanghai, China. Dose-depende nt plas-
mid-constructed ß-actin, HVR2 and CD standards were
used in each run of real-time PCR. Of these, both plas-
mids containing the CD breakpoint and the HVR2 region
were kindly provided by Professor E. Kirches [20]. All
TaqMan reactions were carried out in 96-well plates on
an ABI 7500 Real-Time PCR instrument (Applied Biosys-
tems, Fost er City, CA, USA) using the R eal-Time PCR
Master Mix kit from Toyobo Co. (Osaka , Japan). Each
reaction was carried out in total volume of 25 μlwith
50 ng total DNA template, 300 nM each primer, and
100 nM TaqMan-MGB probe. After an initial denatura-
tion step at 94°C for t hree minutes, 40-45 PCR cycles of
15 s at 94°C, 20 s at 60°C, and 30 s at 72°C were per-
formed. Real-time PCR of all samples and standards were
carried out in quadruplicate. The data from a PCR
run were rejected if the correlation coefficient was less
than 0.98.
Wen et al. Radiation Oncology 2011, 6:133
http://www.ro-journal.com/content/6/1/133
Page 2 of 7
Statistical analysis
All statistical computations were done using the SPSS
v15.0 (SPSS, Chicago, IL). Logarithmi c transformation of
data was essential for further parameter statistical analysis
since the original values of the mtDNA and CD copy
number in lymphocytes showed a nonnormal distribution.
Univariate analysis of variance and Stude nt-Newman-
Keuls post hoc tests were used to analyze the difference in
mtDNA and CD level with IR exposure. The relative
change of mtDNA and CD levels after different dosage
exposure were tested by nonparametric Friedman test.
The Pearsons correlation test was used to explore associa-
tion between mtDNA and CD levels. The correlation
between mtDNA, CD level and gen der, age wa s analyzed
by the nonparametric Spearmans rho correlation test and
the Pearsons correlation test individually. P values < 0.05
are considered statistically significant. All reported
P values are two sided.
Results
Reliability and reproducibility of the TaqMan-MGB PCR
assay
The level of mtDNA and CD from lymphocytes was deter-
mined in a set of independent ex peri ments. First, a Taq-
Man reaction targeting the house keeping gene ß-actin
was used to measure the amount of genomic DNA present
in cells. A second TaqMan assay was designed to the
HVR2 region to quantitate the total amount of mitochon-
drial DNA. The mt DNA content was normalized to the
amount of genomic DNA in a lymphocyte and expressed
as a ratio of mtDNA molecules relative to total genomic
DNA molecules per cell. A third TaqMan assay targeted
the CD breakpoint and measured the abundance of the
CD in the samples. The level of CD was normalized using
mtDNA amount and was expressed as a ratio to the mito-
chondrial DNA amounts. In other words, the CD ratio
was expressed as a percentage of deleted mtDNA mole-
cules relative to total mtDNA molecules in per genomic
DNA molecules. These primer sets have been used exten-
sively for measuring the CD and mtDNA in tissues con-
taining low CD and give reliable results [20,21]. Figure 1
showed the standard curve for the mtDNA common dele-
tion and the CD amplification plots for the samples exam-
ined. It demonstrated that employed TaqMan assay was
sensitive enough to detect single molecule of CD and high
linearity was found (y =3E
-12e-0.6358x
) in the range of stan-
dard samples. CD levels in most of the samples were
detected between Ct 35 and 39. In all samples examined,
PCR products were amplified within the linear range of
assays (r
2
> 0.98). Positive control DNA from a 75 year
old male skeletal muscle contained about 0.729% CD ratio
and most of the lymphocytes samples contained from
0.003% to 0.04% CD ratio, consistent with other measure-
ments [18,22]. These results suggest that the TaqMan-
MGB PCR approach produces high sensitivity, and could
give reliable and corroborating data in our study.
Basal level of mtDNA content and CD ratio from healthy
donors and ALL patients
We first quantified the mtDNA co ntent (median = 197,
minimum = 65, maximum = 1124 in ALL; median = 398,
minimum = 39, maximum = 1283 in healthy donors) and
CD ratio (median = 0.0116%, minimum = 0.0019%, maxi-
mum = 0.085% in ALL; median = 0.0193%, m inimum =
0.0027%, maximum = 0.121%) per cell in PBLs from ALL
patients and healthy donors before irradiation to deter-
mine the distribution pattern. Since both variables did not
show normal distribution (P < 0.01, Kolmogorov-Smirnov
test), a logarithm of the mtDNA content and CD ratio was
made for normal distributions (see details in additional file
1, Figure S1). Data of mtDNA content and CD ratio after
logar ithm in the three study groups (0, 4.5 and 9 Gy TBI
respectively) were given in Table 1 as mean ± SD, median
and range. Mean ± SD values of initial mtDNA and CD
level in healthy donors cohort were at 2.507 ± 0.28 1 and
-3.683 ± 0.414. No statistically significant difference was
found for logarithm of basal mtDNA and CD level
between healthy donors and patients with ALL.
Changes of mtDNA content and CD ratio after TBI in
patients
Next, we investigated whether the irradiation dose has an
effect on mtDNA and CD level with lymphocytes. Signifi-
cant differences were found between IR status and
mtDNA alteration among lymphocytes 24 h after the irra-
diation (P = 0.038 for mtDNA content, 0.027 for CD ratio,
Univariate analysis of variance). Furthermore, Student
Newman-Keuls post-hoc tests were used to compare the
difference among the three groups. mtDNA content was
significantly increased in 4. 5 and 9 Gy irradiation groups
compared with 0 Gy group (mean value of mtDNA con-
tent 2.526 and 2.711 compared with 2.360), as well as CD
ratio reduced in 4.5 and 9 Gy irradiation groups compared
with 0 Gy group (mean value of CD ratio -4.148 and
-4.233 compared with -3.935).
Relative change of mtDNA and CD in lymphocytes from
each patient after TBI
The results above obtained from in vivo lymphocytes iso-
lated from patients suggest a correlation of increased
mtDNA and decreased CD level with dosage (4.5, 9 Gy)
irradiation in cohort study. To better examine the associa-
tion bet ween mtD NA alterations and IR in individuals,
relative changes of mtDNA and CD levels after different
dose TBI were compared for each patient. As shown in
Figure 2, the increase in mtNDA content was average 1.87
and 2.13 times individually after 4.5 and 9 Gy TBI ( P <
0.001, Friedman test). Meanwhile, decrease in CD was
Wen et al. Radiation Oncology 2011, 6:133
http://www.ro-journal.com/content/6/1/133
Page 3 of 7
0.78 and 0.61 when 4.5, 9 vs. 0 Gy cohorts respectively (P
< 0.001, Friedman test). Moreover, significant difference
was observed in mtDNA copy (P = 0.041) and CD ratio (P
< 0.00 1) in each patient when comparing 9 Gy vs. 4.5 Gy
exposure. Besides, proportions of increase d mtDNA con-
tent in lymphocytes was found to be 80.8% (21 /26) and
decreased CD ratio to be 84.6% (22/26) after 4.5 Gy o f
TBI. Similar trends occurred aft er 9 Gy expo sure, where
84.6% of increased m tDNA content (2 2/26) and 88.5% of
decreased CD ratio (23/26) observed.
Relation between mtDNA and CD level after irradiation
No relation was found between the level of mtDNA and
CD at 0, 4.5 and 9 Gy, when they were analyzed as
Figure 1 TaqMan PCR assay for measuring the common mitochondrial deletion in DNA extracted from lymphocytes.Thetoppanel
shows the amplification plot for the standard curve whereas the bottom panel shows the amplification plot for the lymphocyte samples. The
level of the common mitochondrial deletion in the lymphocyte samples is within the linear range of the standard curve.
Wen et al. Radiation Oncology 2011, 6:133
http://www.ro-journal.com/content/6/1/133
Page 4 of 7
continuous variables (Pearson test used in all corre la-
tions). However, when CD values were segregated in
two p opulations (the lower third against the two upper
thirds of the distribution), a modest inverse correlation
was found reaching signi ficant level for mtDNA content
at different dosage (P = 0.037 for 4.5 Gy, 0.048 for 9 Gy,
shown in Figure 3). Besides, significant elevate d mtDNA
content was observed not in high but in low CD popula-
tion (P = 0.021) after 4.5 Gy TBI exposure.
Effect of age and gender
Finally, the correlations betwee n age, gender, mtDNA
and CD level were analyzed individually. No relationship
was found between mtDNA, CD level and gender. How-
ever, a significant positive effect of age was found for
basal logarithm mtDNA content in PBLs. A regression
analysis allowed quantification of the effect of age on
basal mtDNA content (regression coefficient = 0.0085 y-
1; r2 = 0.251; P = 0.011). The corresponding graphs are
presented in Figure 4 . These results suggest that older
people contained higher mtDNA content in general in
the age range of 19-56.
Discussion
In this paper, we described a sensitive and reliable real-
time PCR assay o f identifying the mtDNA and common
deletion levels. As expected, employ ed TaqMa n-MGB
probe was sensitive enough to det ect singl e molecule of
CD in our experiment. The sensitivity increased at least 5
fold compared with non specific SYBR Green dye real-
time PCR experiment [23]. Besides the improvement of
PCR method, we used human tissues and in vivo irradia-
tion model, whereas the cell s trains and ex vivo irradia-
tion model was exclusively used in other studies. As we
known, the ex vivo cultured cells is unlikely to reflect full
view of in vivo microenvironment. What is more, a lots
of apoptotic cell occurs after IR, which is hardly to isolate
from the whole cell population of strain, and will extre-
mely affect the accurate q uantification of mtDNA and
CD level for cell heterogeneity [23]. In contract, lympho-
cytes in vivo mostly consist of survival cells (> 95%) and
could avert the effect of apoptosis [24]. No doubt, it had
integrity advantage and is a big step u p compared to ex
vivo model. Based on t hese evidences above mentioned,
we can declare that direct analysis of lymphocytes
Table 1 Logarithm of mtDNA and CD levels in peripheral blood lymphocytes from patients before and after
irradiation
Group Log (mtDNA content) Log (CD ratio)
Median (range) Mean ± SD Median (range) Mean ± SD
0 Gy 2.294 (1.811~ 3.051) 2.360 ± 0. 320 -3.934 (-4.730 ~ -3.071) -3.935 ± 0.459
4.5 Gy 2.566 (1.950 ~ 3.069) 2.526 ± 0. 384 -4.069 (-4.857 ~ -3.063) -4.148 ± 0. 531
9 Gy 2.715 (1.956 ~ 3.186) 2.711 ± 0. 363 -4.437 (-4.952 ~ -3.255) -4.233 ± 0.527
P
a
0.038 0.027
Abbreviations: SD, standard devitation; CD, common deletion;
P value was demonstrated by univariate analysis of variance.
Figure 2 Relative change of mtDNA content (A) and CD ratio
(B) from patients PBLs (n = 26) after different dose of total
body irradiation therapy. Significant difference was observed in
relative mtDNA (*P = 0.041) and CD (*P < 0.001) change of every
patient when comparing 9 Gy vs. 4.5 Gy exposure. A circle
represents mean value of relative change level from each patient
undergoing irradiation compared to their basal levels. The lines
connect the mean values of relative change level from all cases.
Wen et al. Radiation Oncology 2011, 6:133
http://www.ro-journal.com/content/6/1/133
Page 5 of 7
isolated from human bodies who received TBI would
greatly improve specificity and reliability. These techni-
que refinements take us closer to a methodology that is
likely to produce reliable and quantitative results.
The role of mtDNA content has been investigated in
relation to TBI th erapy for the first time in ALL patients.
The number of mtDNA copies was elevated in lympho-
cytes from above 80% of cases after TBI. Besides, mtDNA
content of irradiated PBLs elevated consisting with a dose
response. This phenomenon has been explained as a com-
pensatory replication of mtDNA to replace damaged
mtDNA
7
.
Our statistic al analysis showed induce d levels of CD
after TBI in PBLs, compared to some other reports that
IR-induced oxidative stress may cause increase of CD
ratio [13,14]. Considering that h igh deletion level of
mtDNA increases the susceptibility of human cell to
apoptosi s[25], the difference is most likely due to the fact
that IR exposure causes lymphocyt es differentiat e into
two major populations immediately: apoptotic population
usually containing relative high CD level a nd thus being
sensitive to apoptosis, while surviving population con-
taining relatively low CD level and more resistant to IR.
The cell source in other studies is li kely mixed w ith
many apoptotic cells, which may resulted in relatively
high CD level detection.
Here, we report a statistical inversely association
between these two predictive values (mtDNA content and
CD ratio) for radiation toxicity. That is to say , lowest
values of CD ratio were related to higher values of mtDNA
content, at the same radiation dose in our experiment. Cell
response to IR is individual, and the amount of initial
mtDNA and CD levels depend on each patient. The
mechanism behind the relationship remai ns unclear. One
possible reason is that lymphocytes containing lower level
of deleted mtDNA h ave stronger ability to replicate wild
mtDNA than cells with high CD level, in order to resist the
irradiation induced mitochondrial damage [26]. Besides,
abundant mtDNA replication only occurred in low CD
population after moderate dosage t reatmen t, which sug-
gests the stronger replication ability of low CD population
and a mass of mtDNA copy number production. However,
the strong replication ability was not shown in high CD
population after modest dosage treatment.
Cellular oxidative stress is thoug ht to play a role in the
aging process and may affect mtDNA replication. In the
present study, we found that mtDNA copy num ber is
increased with age by lineal regression in our limited
cohorts. Similar results has been described that individuals
after middle age may be attributed to the enhanced oxida-
tive stress than young adults [27], suggesting age factor
should be considered when measuring mtDNA content
from both nonirradiated and irradiated lymphocytes.
Conclusion
This study describes the development of a rapid, sensitive,
and p ractical real-time PCR method to quantify the
mtDNA copy number and common deletion in PBL sam-
ples. Our results suggest that radiation increased mtDNA
content and declined common deletion ratio in peripheral
lymphocytes of ALL patients, and an inverse association
was observed bet ween both parameters after irradiation,
Figure 3 Box plot shows an association between CD ratio and
mtDNA content. The lines connect the medians, the boxes cover
the 25
th
to 75
th
percentiles, and the minimal and maximal values
are shown by the ends of the bars. Patients with lower amount of
CD ratio suffered higher levels of mtDNA.
Figure 4 Regression analysi s of the relationship between age
and basal mtDNA content from patients lymphocytes (n = 26).
Wen et al. Radiation Oncology 2011, 6:133
http://www.ro-journal.com/content/6/1/133
Page 6 of 7
which may be considered as predictive factors to radiation
toxicity.
Additional material
Additional file 1: Figure S1. The histograms show the frequency
distribution of logarithm of both mtDNA content (A) and CD ratio (B)
from patients (n = 26) after different dose of irradiation. Both population
showed normal distributions (P = 0.488 and P = 0.753 respectively,
Kolmogorov-Smirnov test).
List of abbreviations
mtDNA: mitochondrial DNA; CD: common deletion; PB: peripheral blood; PBLs:
peripheral blood lymphocytes; TBI: total body irradiation; IR: ionizing radiation;
HVR2: hypervariable region 2; nDNA: nuclear DNA; ALL: acute lymphoblastic
leukemia; MGB: minor groove binder; ROS: reactive oxygen species.
Acknowledgements
We would like to acknowledge Professor E. Kirches for his assistance with
plasmids donation. We are indebted to associate Professor Jieqiong Lei
(Mathematics department, College of biotechnology, TMMU University) for
statistical assistance, to the patients and donors who donated blood for this
study. This study was supported by grants from the Keystone Project of the
Eleventh Five-year Plan for Medical Science Development of PLA (No.06G068)
and the National Natural Science Foundation of China (No.30772144).
Author details
1
Third Department of Oncology, The second affiliated hospital, Third Military
Medical University, Chongqing 400037, China.
2
Institute of Human
Respiratory Disease, The second affiliated hospital, Third Military Medical
University, Chongqing 400037, China.
Authors contributions
QW and YH designed the study, FJ provided real-time PCR assay, QW
analyzed the data and written the paper, GQ contributed to revising the
paper. All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 26 May 2011 Accepted: 6 October 2011
Published: 6 October 2011
References
1. Iliakis G, Wang H, Perrault AR, Boecker W, Rosidi B, Windhofer F, Wu W,
Guan J, Terzoudi G, Pantelias G: Mechanisms of DNA double strand break
repair and chromosome aberration formation. Cytogenet Genome Res
2004, 104:14-20.
2. Purkayastha S, Milligan JR, Bernhard WA: On the chemical yield of base
lesions, strand breaks, and clustered damage generated in plasmid DNA
by the direct effect of × rays. Radiat Res 2007, 168:357-366.
3. Yakes FM, Van Houten B: Mitochondrial DNA damage is more extensive
and persists longer than nuclear DNA damage in human cells following
oxidative stress. Proc Natl Acad Sci USA 1997, 94:514-519.
4. Rodemann HP, Blaese MA: Responses of normal cells to ionizing
radiation. Elsevier 2007, 81-88.
5. Larsen NB, Rasmussen M, Rasmussen LJ: Nuclear and mitochondrial DNA
repair: similar pathways? Mitochondrion 2005, 5:89-108.
6. Yang JL, Weissman L, Bohr VA, Mattso n MP: Mitochondrial DNA damage
and repair in neurodegenerative disorders. DNA repair 2008,
7:1110-1120.
7. Zhang H, Maguire D, Swarts S, Sun W, Yang S, Wang W, Liu C, Zhang M,
Zhang D, Zhang L, et al: Replication of murine mitochondrial DNA
following irradiation. Adv Exp Med Biol 2009, 645:43-48.
8. Cortopassi GA, Arnheim N: Detection of a specific mitochondrial DNA
deletion in tissues of older humans. Nucleic Acids Res 1990, 18:6927-6933.
9. Krishnan KJ, Reeve AK, Samuels DC, Chinnery PF, Blackwood JK, Taylor RW,
Wanrooij S, Spelbrink JN, Lightowlers RN, Turnbull DM: What causes
mitochondrial DNA deletions in human cells? Nat Genet 2008, 40:275-279.
10. Gerhard GS, Benko FA, Allen RG, Tresini M, Kalbach A, Cristofalo VJ, Gocke CD:
Mitochondrial DNA mutation analysis in human skin fibroblasts from
fetal, young, and old donors. Mech Ageing Dev 2002, 123:155-166.
11. Chabi B, Mousson de Camaret B, Chevrollier A, Boisgard S, Stepien G:
Random mtDNA deletions and functional consequence in aged human
skeletal muscle. Biochem Biophys Res Commun 2005, 332:542-549.
12. Pavicic WH, Richard SM: Correlation analysis between mtDNA 4977-bp
deletion and ageing. Mutat Res 2009, 670:99-102.
13. Prithivirajsingh S, Story MD, Bergh SA, Geara FB, Ang KK, Ismail SM,
Stevens CW, Buchholz TA, Brock WA: Accumulation of the common
mitochondrial DNA deletion induced by ionizing radiation. Febs Letters
2004, 571:227-232.
14. Kubota N, Hayashi J, Inada T, Iwamura Y: Induction of a particular deletion
in mitochondrial DNA by × rays depends on the inherent
radiosensitivity of the cells. Radiat Res 1997, 148
:395-398.
15. Wardell TM, Ferguson E, Chinnery PF, Borthwick GM, Taylor RW, Jackson G,
Craft A, Lightowlers RN, Howell N, Turnbull DM: Changes in the human
mitochondrial genome after treatment of malignant disease. Mutat Res
2003, 525:19-27.
16. Willoughby K, Valdazo-Gonzalez B, Maley M, Gilray J, Nettleton PF:
Development of a real time RT-PCR to detect and type ovine
pestiviruses. J Virol Methods 2006, 132:187-194.
17. Ribera JM, Oriol A, Bethencourt C, Parody R, Hernandez-Rivas JM,
Besalduch J, Sanz MA, Arias J, Fernandez-Calvo J, Moraleda JM, et al:
Comparison of intensive chemotherapy, allogeneic or autologous stem
cell transplantation as post-remission treatment for adult patients with
high-risk acute lymphoblastic leukemia. Final results of the PETHEMA
ALL-93 Trial. Bone Marrow Transplantation 2005, 35:S14-S14.
18. Moraes CT, Sciacco M, Ricci E, Tengan CH, Hao H, Bonilla E, Schon EA,
DiMauro S: Phenotype-genotype correlations in skeletal muscle of
patients with mtDNA deletions. Muscle Nerve 1995, 3:S150-153.
19. Yao Y, Kong Q, Bandelt H, Kivisild T, Zhang Y: Phylogeographic
differentiation of mitochondrial DNA in Han Chinese. The American
Journal of Human Genetics 2002, 70:635-651.
20. Sabunciyan S, Kirches E, Krause G, Bogerts B, Mawrin C, Llenos IC, Weis S:
Quantification of total mitochondrial DNA and mitochondrial common
deletion in the frontal cortex of patients with schizophrenia and bipolar
disorder. Journal of Neural Transmission 2007, 114:665-674.
21. Pogozelski WK, Hamel CJ, Woeller CF, Jackson WE, Zullo SJ, Fischel-
Ghodsian N, Blakely WF: Quantification of total mitochondrial DNA and
the 4977-bp common deletion in Pearsons syndrome lymphoblasts
using a fluorogenic 5-nuclease (TaqMan) real-time polymerase chain
reaction assay and plasmid external calibration standards. Mitochondrion
2003, 2:415-427.
22. Mohamed SA, Wesch D, Blumenthal A, Bruse P, Windler K, Ernst M, Kabelitz D,
Oehmichen M, Meissner C: Detection of the 4977 bp deletion of
mitochondrial DNA in different human blood cells. Experimental Gerontology
2004, 39:181-188.
23. Wang L, Kuwahara Y, Li L, Baba T, Shin RW, Ohkubo Y, Ono K, Fukumoto M:
Analysis of Common Deletion (CD) and a novel deletion of
mitochondrial DNA induced by ionizing radiation. International Journal of
Radiation Biology 2007, 83:433-442.
24. Schmitz A, Bayer J, Dechamps N, Thomas G: Intrinsic susceptibility to
radiation-induced apoptosis of human lymphocyte subpopulations.
International Journal of Radiation Oncology Biology Physics 2003, 57:769-778.
25. Liu CY, Lee CF, Hong CH, Wei YH: Mitochondrial DNA mutation and
depletion increase the susceptibility of human cells to apoptosis. Ann N
Y Acad Sci 2004, 1011:133-145.
26. Wai T, Teoli D, Shoubridge EA: The mitochondrial DNA genetic bottleneck
results from replication of a subpopulation of genomes. Nature Genetics
2008, 40:1484-1488.
27. Liu CS, Tsai CS, Kuo CL, Chen HW, Lii CK, Ma YS, Wei YH: Oxidative stress-
related alteration of the copy number of mitochondrial DNA in human
leukocytes. Free Radic Res 2003, 37:1307-1317.
doi:10.1186/1748-717X-6-133
Cite this article as: Wen et al.: Mitochondrial DNA alterations of
peripheral lymphocytes in acute lymphoblastic leukemia patients
undergoing total body irradiation therapy. Radiation Oncology 2011 6:133.
Wen et al. Radiation Oncology 2011, 6:133
http://www.ro-journal.com/content/6/1/133
Page 7 of 7

Supplementary resource (1)

... 9,[18][19][20][21][22][23][24][25][26][27] In humans, the relationship between high levels of ionizing radiation and mtDNA damage has been only recently reported. 28 In an interesting study by Wen and colleagues, increased mtDNA-CN and a declined common deletion ratio have been found in peripheral blood of cancer patients undergoing total body irradiation, suggesting the potential role of mtDNA damage as a predictive factor of radiation toxicity. 28 Contrariwise, there is no evidence regarding the possible changes in mtDNA after low-dose human exposures. ...
... 28 In an interesting study by Wen and colleagues, increased mtDNA-CN and a declined common deletion ratio have been found in peripheral blood of cancer patients undergoing total body irradiation, suggesting the potential role of mtDNA damage as a predictive factor of radiation toxicity. 28 Contrariwise, there is no evidence regarding the possible changes in mtDNA after low-dose human exposures. To the best of our knowledge, this is the first study to show that mtDNA4977 deletion was significantly increased in Cath Lab personnel professionally exposed to chronic low-dose ionizing radiation as compared with an unexposed group. ...
... 40 Our findings are in line with previous observations supporting the notion that enhanced replication of mtDNA copies may reduce the frequency of mutations and delay the onset of ionizing radiation damage to mitochondria. 21,28 Once again, ionizing radiation exposure appears to be a double-edged sword, with adaptive and possibly beneficial effects intertwined with detrimental, maladaptive changes. In the short run and for modest exposure, the effects of ionizing radiation on mitochondrial function may mirror a possibly beneficial supernormal adaptation with increased mtDNA-CN and only a modest increase in mtDNA deletion. ...
Article
Aims: Ionizing radiation may lead to mitochondrial DNA (mtDNA) mutations and changes in mtDNA content in cells, major driving mechanisms for carcinogenesis, vascular aging and neurodegeneration. The aim of this study was to investigate the possible induction of common mitochondrial deletion (mtDNA4977) and mtDNA copy number (mtDNA-CN) changes in peripheral blood of personnel working in high-volume cardiac catheterization laboratories (Cath Labs). Methods: A group of 147 Cath Lab workers (median individual effective dose = 16.8 mSv, for the 41 with lifetime dosimetric record) and 74 unexposed individuals were evaluated. The occupational radiological risk score was computed for each subject on the basis of the length of employment, individual caseload and proximity to the radiation source. mtDNA4977 deletion and mtDNA-CN were assessed by using quantitative real-time polymerase chain reaction. Results: Increased levels of mtDNA4977 deletion were observed in high-exposure Cath Lab workers compared with unexposed individuals ( p < 0.0001). Conversely, mtDNA-CN was significantly greater in the low-exposure workers ( p = 0.003). Occupational radiological risk score was positively correlated with mtDNA4977 deletion (Spearman's r = 0.172, p = 0.03) and inversely correlated with mtDNA-CN (Spearman's r = -0.202, p = 0.01). In multiple regression model, occupational radiological risk score emerged as significant predictor of high levels of mtDNA4977 deletion (ß coefficient = 0.236, p = 0.04). Conclusion: mtDNA4977 deletion is significantly high in Cath Lab personnel. Beyond the well-recognized nuclear DNA, mtDNA damage might deserve attention as a pathogenetic molecular pathway and a potential therapeutic target of ionizing radiation damage.
... Findings have demonstrated that CD can be a precise indicator of oxidative damage to mtDNA [43][44][45]. Wen et al. studied mtDNA modifications in irradiated human peripheral lymphocytes from acute lymphoblastic leukemia (ALL) subjects [46]. Significant inverse correlation was demonstrated between CD level and mtDNA content. ...
... Significant inverse correlation was demonstrated between CD level and mtDNA content. CD content and mtDNA may be believed as prognostic factors to radiation toxicity [46]. However, it is well known that the post-irradiation injuries in the BM and diverse organs represent a main problem and are the principal reasons of post-irradiation mortality and morbidity [47]. ...
Article
Full-text available
Radiation therapy plays a critical role in the management of a wide range of hematologic malignancies. It is well known that the post-irradiation damages both in the bone marrow and in other organs are the main causes of post-irradiation morbidity and mortality. Tumor control without producing extensive damage to the surrounding normal cells, through the use of radioprotectors, is of special clinical relevance in radiotherapy. An increasing amount of data is helping to clarify the role of oxidative stress in toxicity and therapy response. Radioprotective agents are substances that moderate the oxidative effects of radiation on healthy normal tissues while preserving the sensitivity to radiation damage in tumor cells. As well as the substances capable of carrying out a protective action against the oxidative damage caused by radiotherapy, other substances have been identified as possible enhancers of the radiotherapy and cytotoxic activity via an oxidative effect. The purpose of this review was to examine the data in the literature on the possible use of old and new substances to increase the efficacy of radiation treatment in hematological diseases and to reduce the harmful effects of the treatment.
... In vivo, evidence was found that radiotherapy (RT) is associated with an increase in mitochondrial genome mutation rate [11]. Encouragingly, Wen et al. have reported an increase in mtDNA deletions in peripheral lymphocytes of acute lymphoblastic leukemia patients undergoing total body irradiation (TBI) therapy [12]. Philips et al. recently reported a sensitive multiplex real-time polymerase chain reaction (MQRT-PCR) assay for simultaneous quantification of mitochondrial DNA copy number and deletion ratio for quantification of mtDNA site in the minor arc (mtMin) where large deletions are rare and another mtDNA site in the major arc (mtMaj) where large deletions are common. ...
... Furthermore, Wen et al. studied mtDNA content and common deletion levels in another set of 26 TBI patients by quantitative PCR. They reported significant modifications of both parameters and proposed them as predictive factors to radiation toxicity [12]. However, in our conditions we did not find any significant change in mtDNA deletion, possibly because we used PBI patients with lower mean blood doses. ...
Article
Full-text available
The increasing risk of acute large-scale radiological/nuclear exposures of population underlines the necessity of developing new, rapid and high throughput biodosimetric tools for estimation of received dose and initial triage. We aimed to compare the induction and persistence of different radiation exposure biomarkers in human peripheral blood in vivo. Blood samples of patients with indicated radiotherapy (RT) undergoing partial body irradiation (PBI) were obtained soon before the first treatment and then after 24 h, 48 h, and 5 weeks; i.e. after 1, 2, and 25 fractionated RT procedures. We collected circulating peripheral blood from ten patients with tumor of endometrium (1.8 Gy per fraction) and eight patients with tumor of head and neck (2.0–2.121 Gy per fraction). Incidence of dicentrics and micronuclei was monitored as well as determination of apoptosis and the transcription level of selected radiation-responsive genes. Since mitochondrial DNA (mtDNA) has been reported to be a potential indicator of radiation damage in vitro, we also assessed mtDNA content and deletions by novel multiplex quantitative PCR. Cytogenetic data confirmed linear dose-dependent increase in dicentrics (p < 0.01) and micronuclei (p < 0.001) in peripheral blood mononuclear cells after PBI. Significant up-regulations of five previously identified transcriptional biomarkers of radiation exposure (PHPT1, CCNG1, CDKN1A, GADD45, and SESN1) were also found (p < 0.01). No statistical change in mtDNA deletion levels was detected; however, our data indicate that the total mtDNA content decreased with increasing number of RT fractions. Interestingly, the number of micronuclei appears to correlate with late radiation toxicity (r² = 0.9025) in endometrial patients suggesting the possibility of predicting the severity of RT-related toxicity by monitoring this parameter. Overall, these data represent, to our best knowledge, the first study providing a multiparametric comparison of radiation biomarkers in human blood in vivo, which have potential for improving biological dosimetry.
... One study of tissue samples from patients with clear cell carcinoma linked higher mitochondrial mass with reduced tumor aggressiveness (83). Presumably, an increase in mitochondrial content could lead to subsequent strains on resources in highly proliferative cancer cells (81,84,85). In addition to causing increases mtDNA and PGC-1a, radiation can also inhibit mitochondrial respiration. ...
Article
Full-text available
The role of mitochondria in cancer formation and progression has been studied extensively, but much remains to be understood about this complex relationship. Mitochondria regulate many processes that are known to be altered in cancer cells, from metabolism to oxidative stress to apoptosis. Here, we review the evolving understanding of the role of mitochondria in cancer cells, and highlight key evidence supporting the role of mitochondria in cancer immune evasion and the effects of mitochondria-targeted antitumor therapy. Also considered is how knowledge of the role of mitochondria in cancer can be used to design and improve cancer therapies, particularly immunotherapy and radiation therapy. We further offer critical insights into the mechanisms by which mitochondria influence tumor immune responses, not only in cancer cells but also in immune cells. Given the central role of mitochondria in the complex interactions between cancer and the immune system, high priority should be placed on developing rational strategies to address mitochondria as potential targets in future preclinical and clinical studies. We believe that targeting mitochondria may provide additional opportunities in the development of novel antitumor therapeutics.
... There is extensive literature on the increase in the number of mtDNA copies in response to ionizing radiation [13][14][15]. It is interesting to note that the effect of increasing mtDNA CN in untreated SZ-2 (m-) patients (average 2.8-fold compared with the control) is comparable to the effect of increasing mtDNA CN in leukemia patients undergoing total body irradiation therapy with a dose of 9 Gy (average 2.3-fold [36]). This may indicate that the levels of oxidative stress in some schizophrenia patient are comparable to the level of oxidative stress induced by sufficiently high doses of ionizing radiation. ...
Article
Full-text available
OBJECTIVE: The aim of this study was: (1) to examine the leukocyte mtDNA copy number (CN) in unmedicated (SZ (m-)) and medicated (SZ (m+)) male patients with paranoid schizophrenia (SZ) in comparison with the healthy male controls (HC) and (2) to compare the leukocyte mtDNA CN with the content of an oxidation marker 8-oxodG in lymphocytes of the SZ (m-) patients. METHODS: We evaluated leukocyte mtDNA CN of 110 subjects with SZ in comparison with 60 male HC by the method qPCR (ratio mtDNA/nDNA (gene B2M) was detected). SZ patients were divided into two subgroups. The patients of the subgroups SZ (m+) (N=55) were treated with standard antipsychotic medications in the hospital. The patients of the subgroup SZ (m-) (N =55) were not treated before venous blood was sampled. To evaluate oxidative DNA damage we quantified the levels of 8-oxodG in lymphocytes (flow cytometry) of SZ (m-) patients (N=55) and HC (N=30). RESULTS: The leukocyte mtDNA CN showed no significant difference in SZ (m+) patients and HC. The mtDNA CN in the unmedicated subgroup SZ (m-) was significantly higher than that in the SZ (m+) subgroup or in HC group. The level of 8-oxodG in the subgroup SZ (m-) was significantly higher than that in HC group. CONCLUSION: The leukocytes of the unmedicated SZ male patients with acute psychosis contain more mtDNA than the leukocytes of the male SZ patients treated with antipsychotic medications or the healthy controls. MtDNA content positively correlates with the level of 8-oxodG in the unmedicated SZ patients. Highlights  Unmedicated SZ men contain more mtDNA in leukocytes than medicated ones and control 2  Unmedicated SZ men contain more 8-oxodG in lymphocytes than healthy control  MtDNA content positively correlates with the level of 8-oxodG in unmedicated SZ patients
... There is extensive literature on the increase in the number of mtDNA copies in response to ionizing radiation [13][14][15]. It is interesting to note that the effect of increasing mtDNA CN in untreated SZ-2 (m-) patients (average 2.8-fold compared with the control) is comparable to the effect of increasing mtDNA CN in leukemia patients undergoing total body irradiation therapy with a dose of 9 Gy (average 2.3-fold [36]). This may indicate that the levels of oxidative stress in some schizophrenia patient are comparable to the level of oxidative stress induced by sufficiently high doses of ionizing radiation. ...
Article
Full-text available
OBJECTIVE: The aim of this study was: (1) to examine the leukocyte mtDNA copy number (CN) in unmedicated (SZ (m-)) and medicated (SZ (m+)) male patients with paranoid schizophrenia (SZ) in comparison with the healthy male controls (HC) and (2) to compare the leukocyte mtDNA CN with the content of an oxidation marker 8-oxodG in lymphocytes of the SZ (m-) patients. METHODS: We evaluated leukocyte mtDNA CN of 110 subjects with SZ in comparison with 60 male HC by the method qPCR (ratio mtDNA/nDNA (gene B2M) was detected). SZ patients were divided into two subgroups. The patients of the subgroups SZ (m+) (N=55) were treated with standard antipsychotic medications in the hospital. The patients of the subgroup SZ (m-) (N =55) were not treated before venous blood was sampled. To evaluate oxidative DNA damage we quantified the levels of 8-oxodG in lymphocytes (flow cytometry) of SZ (m-) patients (N=55) and HC (N=30). RESULTS: The leukocyte mtDNA CN showed no significant difference in SZ (m+) patients and HC. The mtDNA CN in the unmedicated subgroup SZ (m-) was significantly higher than that in the SZ (m+) subgroup or in HC group. The level of 8-oxodG in the subgroup SZ (m-) was significantly higher than that in HC group. CONCLUSION: The leukocytes of the unmedicated SZ male patients with acute psychosis contain more mtDNA than the leukocytes of the male SZ patients treated with antipsychotic medications or the healthy controls. MtDNA content positively correlates with the level of 8-oxodG in the unmedicated SZ patients.
... In 1989, Linnane et al. showed that somatic mutations in mtDNA may cause degenerative diseases and aging (7). These first studies have been followed by numerous studies investigating the relationship of mtDNA damage in various diseases including types of cancer and oxidative stress related diseases such as aging, Parkinson's Disease, Myocardial Infarction and atherosclerosis (8)(9)(10)(11)(12)(13)(14)(15)(16)(17). ...
Article
Full-text available
It has been suggested that heavy exercise might increase oxidative stress, causing mitochondrial DNA (mtDNA) mutations as well as DNA mutations and changes in the mtDNA copy number in cells. mtDNA4977 deletion is one of the most common deletions seen on mitochondria. We hypothesize association between exercise induced oxidative stress and mtDNA damage in peripheral blood lymphocytes (PBLs) of highly trained swimmers. Therefore we studied the mtDNA4977 deletion level, mtDNA copy number and their relationship with cellular ATP and oxidative stress status in PBLs of swimmers. 8 highly trained and 8 normal trained swimmers and 8 non-athlete subjects were included in the study. The mtDNA4977 deletion and amount of mtDNA were measured using RT-PCR method whereas dichlorohydrofluoroscein (DCF) assay method was used to assess cellular oxidative stress and ATP levels were measured using bioluminescence method. Even though an increase in mtDNA4977 deletion was found in all study groups, the difference was not statistically significant (p=0.98). The mtDNA copy numbers were found to be surprisingly high in highly trained swimmers compared to normal trained swimmers and non-athlete subjects by 4.03 fold (p= 0.0002) and 5.58 fold (p=0.0003), respectively. No significant differences were found between groups by means of intracellular ATP levels (p=0.406) and oxidative stress (p=0.430). No correlation was found between mtDNA copy number and intracellular ATP content of the PBLs (p=0.703). Our results suggest that heavy training does not have a specific effect on mtDNA4977 deletion but it may be affecting mitochondrial copy numbers which may act as a compensatory mechanism related to ATP levels in blood.
Article
In this work, individual radiosensitivity was evaluated using DNA damage response and chromosomal aberrations (CAs) in peripheral blood lymphocytes (PBLs) for the prediction of acute toxicities of chemoradiotherapy (CRT) in esophageal cancer patients. Eighteen patients with esophageal cancer were enrolled in this prospective study. Prescribed doses were 60 Gy in 11 patients and 50 Gy in seven patients. Patients received 2 Gy radiotherapy five days a week. PBLs were obtained during treatment just before and 15 min after 2 Gy radiation therapy on the days when the cumulative dose reached 2, 20, 40 Gy and 50 or 60 Gy. PBLs were also obtained four weeks and six months after radiotherapy in all and 13 patients, respectively. Dicentric and ring chromosomes in PBLs were counted to evaluate the number of CAs. Gamma-H2AX foci per cell were scored to assess DNA double-strand breaks. We analyzed the association between these factors and adverse events. The number of γ-H2AX foci before radiotherapy showed no significant increase during CRT, while their increment was significantly reduced with the accumulation of radiation dose. The mean number of CAs increased during CRT up to 1.04 per metaphase, and gradually decreased to approximately 60% six months after CRT. Five patients showed grade 3 toxicities during or after CRT (overreactors: OR), while 13 had grade 2 or less toxicities (non-overreactors: NOR). The number of CAs was significantly higher in the OR group than in the NOR group at a cumulative dose of 20 Gy (mean value: 0.63 vs. 0.34, P = 0.02), 40 Gy (mean value: 0.90 vs. 0.52, P = 0.04), and the final day of radiotherapy (mean value: 1.49 vs. 0.84, P = 0.005). These findings suggest that number of CAs could be an index for predicting acute toxicities of CRT for esophageal cancer.
Article
Full-text available
Survivors of childhood acute lymphoblastic leukemia (cALL) are at higher risk of developing cardiometabolic complications. We aimed at exploring the associations between biomarkers of inflammation, oxidative stress, endothelial function, endotoxemia and cardiometabolic risk factors. We conducted a cross-sectional analysis in 246 cALL survivors (mean age, 22.1 ± 6.3 years; mean time since diagnosis, 15.5 ± 5.2 years) and evaluated the associations using a series of logistic regressions. Using structural equation models, we also tested if the relationship between endotoxemia and cardiometabolic complications was mediated by the latent (unobserved) variable inflammation inferred from the observed biomarkers CRP, TNF-α and IL-6. High leptin-adiponectin ratio was associated with obesity [adjusted OR = 15.7; 95% CI (6.2–39.7)], insulin resistance [20.6 (5.2–82.1)] and the metabolic syndrome [11.2 (2.6–48.7)]. Higher levels of plasminogen activator inhibitor-1 and tumor necrosis factor-α were associated with obesity [3.37 (1.6–7.1) and 2.34 (1.3–4.2), respectively] whereas high C-reactive protein levels were associated with insulin resistance [3.3 (1.6–6.8)], dyslipidemia [2.6 (1.4–4.9)] and MetS [6.5 (2.4–17.9)]. Our analyses provided evidence for a directional relationship between lipopolysaccharide binding protein, related to metabolic endotoxemia, inflammation and cardiometabolic outcomes. Identification of biomarkers and biological mechanisms could open new avenues for prevention strategies to minimize the long-term sequelae, improve follow-up and optimize the quality of life of this high-risk population.
Article
The present study illustrates mitochondria-mediated impact of ionizing radiation showing that are paralleled by activation of several pro-adaptive responses in normal human dermal fibroblast cells. Irradiation of cells with X-rays (5 Gy) led to an increase in fragmentation and mitochondrial mass. Distinct temporal changes in cytosolic and mitochondrial reactive oxygen species (ROS) were noted in response to radiation, which was associated with depletion in mitochondrial membrane potential followed by decrease in ATP levels. Long Amplicon-Polymerase Chain Reaction (LA-PCR) analysis showed time-dependent increase in mitochondrial DNA damage that preceded mitochondrial ROS generation. Irradiation of cells led to an initial G2/M arrest at 8 h that persisted till 16 h, with subsequent block at G0/G1 measured at 48 and 72 h time points. Interestingly, cells activated autophagy as a countermeasure against radiation-mediated cellular insults and aided in removal of damaged mitochondria. Blocking autophagy using 3-methyladenine led to cell death via activation of enhanced ROS, PARP-1 and caspase 3 cleavage. Upregulation of mitochondrial biogenesis factors Nrf1/PGC-1α, following irradiation was observed. Irradiated cells exhibited an increase in the phosphorylation of GCN2, PERK and eIF2α that might be responsible for the up-regulation of ATF4 and CHOP thereby regulating autophagy and components of integrated stress response. Apart from this, we measured accumulation of mitochondrial chaperones (HSP60/HSP10) and ATF5 which is a major molecule involved in mitochondrial stress. Taken together, mitochondria are one of the major cytoplasmic targets for ionizing radiation and possibly act as an early indicator of cellular insult. The findings also show that stressed mitochondria might influence endoplasmic reticulum (ER)-related signalling leading to the activation of adaptive mechanisms like cytoprotective autophagy, and molecules responsible for mitochondrial biogenesis and protein quality control in order to replenish mitochondrial pool and maintain cellular homeostasis.
Article
Full-text available
To characterize the mitochondrial DNA (mtDNA) variation in Han Chinese from several provinces of China, we have sequenced the two hypervariable segments of the control region and the segment spanning nucleotide positions 10171–10659 of the coding region, and we have identified a number of specific coding-region mutations by direct sequencing or restriction-fragment–length–polymorphism tests. This allows us to define new haplogroups (clades of the mtDNA phylogeny) and to dissect the Han mtDNA pool on a phylogenetic basis, which is a prerequisite for any fine-grained phylogeographic analysis, the interpretation of ancient mtDNA, or future complete mtDNA sequencing efforts. Some of the haplogroups under study differ considerably in frequencies across different provinces. The southernmost provinces show more pronounced contrasts in their regional Han mtDNA pools than the central and northern provinces. These and other features of the geographical distribution of the mtDNA haplogroups observed in the Han Chinese make an initial Paleolithic colonization from south to north plausible but would suggest subsequent migration events in China that mainly proceeded from north to south and east to west. Lumping together all regional Han mtDNA pools into one fictive general mtDNA pool or choosing one or two regional Han populations to represent all Han Chinese is inappropriate for prehistoric considerations as well as for forensic purposes or medical disease studies.
Article
Full-text available
A significant amount of reactive oxygen species (ROS) is generated during mitochondrial oxidative phosphorylation. Several studies have suggested that mtDNA may accumulate more oxidative DNA damage relative to nuclear DNA. This study used quantitative PCR to examine the formation and repair of hydrogen peroxide-induced DNA damage in a 16.2-kb mitochondrial fragment and a 17.7-kb fragment flanking the beta-globin gene. Simian virus 40-transformed fibroblasts treated with 200 microM hydrogen peroxide for 15 or 60 min exhibited 3-fold more damage to the mitochondrial genome compared with the nuclear fragment. Following a 60-min treatment, damage to the nuclear fragment was completely repaired within 1.5 hr, whereas no DNA repair in the mitochondrion was observed. Mitochondrial function, as assayed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide reduction, also showed a sharp decline. These cells displayed arrested-cell growth, large increases in p21 protein levels, and morphological changes consistent with apoptosis. In contrast, when hydrogen peroxide treatments were limited to 15 min, mtDNA damage was repaired with similar kinetics as the nuclear fragment, mitochondrial function was restored, and cells resumed division within 12 hr. These results indicate that mtDNA is a critical cellular target for ROS. A model is presented in which chronic ROS exposure, found in several degenerative diseases associated with aging, leads to decreased mitochondrial function, increased mitochondrial-generated ROS, and persistent mitochondrial DNA damage. Thus persistent mitochondrial DNA damage may serve as a useful biomarker for ROS-associated diseases.
Article
In mammals, mitochondrial DNA (mtDNA) sequence variants are observed to segregate rapidly between generations despite the high mtDNA copy number in the oocyte. This has led to the concept of a genetic bottleneck for the transmission of mtDNA, but the mechanism remains contentious. Several studies have suggested that the bottleneck occurs during embryonic development, as a result of a marked reduction in germline mtDNA copy number. Mitotic segregation of mtDNAs during preimplantation, or during the expansion of primordial germ cells (PGCs) before they colonize the gonad, is thought to account for the increase in genotypic variance observed among mature oocytes from heteroplasmic mothers. This view has, however, been challenged by studies suggesting that the bottleneck occurs without a reduction in germline mtDNA content. To resolve this controversy, we measured mtDNA heteroplasmy and copy number in single germ cells isolated from heteroplasmic mice. By directly tracking the evolution of mtDNA genotypic variance during oogenesis, we show that the genetic bottleneck occurs during postnatal folliculogenesis and not during embryonic oogenesis.
Article
Radiation-induced alterations in cellular tissue homeostasis triggered by various molecular responses at the level of inter- and intracellular signaling processes cause both acute and late effects in normal tissue after radiation therapy. Some of the underlying molecular and cellular response pathways leading to radiation-induced tissue remodeling will be discussed, with special emphasis on vascular and parenchymal tissues.
Article
Mitochondrial DNA 4977-bp deletion (common deletion) has been associated with ageing human tissues and a few studies have demonstrated their presence in breast cancer patients too; however, no previous publication evaluated both topics in the same samples group. First, when analyzing 95 breast cancer patients, we found a higher percentage of cases carrying the deletion in non-tumoral tissue 73.68% (70/95) than in the tumoral counterparts 45.26% (43/95), showing that the 4977-bp deletion is a phenomenon which commonly appear first in the non-tumoral breast tissue rather than tumoral tissue. Secondly, we analyzed and compared the ageing related distribution of the common deletion rates, in a control group of 199 samples (ages ranging from 10 to 80 years), with those found in cancer patients. Significant correlation was observed in control cases, between individual age ranges and rates of deletion (chi2: 23.21 and p<0.01). In contrast, non-tumoral breast tissue did not show a pattern of correlation, chi2: 0.042 and p: 0.837. However, interestingly, we found that the risk of having deleted mtDNAs was higher for non-tumoral breast samples than for the control group samples, OR: 2.32 [1.22-4.42, 95% CI]; this could be reflecting that other mechanisms are involved in mitochondrial genome deletion increased rate detected in breast cancer cases, than the normal ageing process.
Article
The effect of radiation on the mitochondrial genome in vivo is largely unknown. Though mitochondrial DNA (mtDNA) is vital for cellular survival and proliferation, it has little DNA repair machinery compared with nuclear DNA (nDNA). A better understanding of how radiation affects mtDNA should lead to new approaches for radiation protection. We have developed a new system using real-time PCR that sensitively detects the change in copy number of mtDNA compared with nDNA. In each sample, the DNA sequence coding 18S rRNA served as the nDNA reference in a run simultaneously with a mtDNA sequence. Small bowel collected 24 hours after 2 Gy or 4 Gy total body irradiation (TBI) exhibited increased levels of mtDNA compared with control mice. A 4 Gy dose produced a greater effect than 2 Gy. Similarly, in bone marrow collected 24 hours after 4 Gy or 7 Gy TBI, 7 Gy produced a greater response than 4 Gy. As a function of time, a greater effect was seen at 48 hours compared with 24 hours. In conclusion, we found that radiation increased the ratio of mtDNA:nDNA and that this effect seems to be tissue independent and seems to increase with radiation dose and duration following radiation exposure.
Article
Using PCR, we found that normal heart muscle and brain from adult human individuals contain low levels of a specific mitochondrial DNA deletion, previously found only in patients affected with certain types of neuromuscular disease. This deletion was not observed in fetal heart or brain. Experimental tests support the idea that the deletion exists in vivo in adult mitochondria and Is not an in vitro artifact of PCR. Our data provide direct experimental support for the idea that accumulation of mitochondrial DNA deletions may be Important in aging.
Article
Large-scale deletions of mitochondrial DNA (mtDNA) have been associated with a subgroup of mitochondrial encephalomyopathies, usually characterized by progressive external ophthalmoplegia (PEO) and mitochondrial proliferation in muscle fibers. We and others have shown that muscle from patients with mtDNA deletions have variable cytochrome c oxidase (COX) deficiency and reduction of mitochondrially-synthesized polypeptides in affected muscle fibers. The present work summarizes the phenotype-genotype correlations observed in patients' muscle. In situ hybridization revealed that, while most COX-deficient fibers had increased levels of mutant mtDNA, they almost invariably had reduced levels of normal mtDNA. PCR quantitation of both deleted and wild-type mtDNAs in normal and respiration-deficient muscle fibers from patients with the "common deletion" showed that deleted mtDNAs were present in normal fibers (31 +/- 26%), but their percentages were much higher in affected fibers (95% +/- 2%). Absolute levels of deleted mtDNA were also increased in affected fibers, whereas absolute levels of wild-type mtDNA were significantly reduced. Taken together, our results suggest that although a specific ratio between mutant and wild-type mitochondrial genomes is probably the major determinant of the respiratory chain deficiency associated with mtDNA deletions, the reduction in the absolute amounts of wild-type mtDNA may also play a significant pathogenetic role.